Assessment of Resistance Mechanisms and Clinical Implications in Patients With<i>EGFR</i>T790M–Positive Lung Cancer and Acquired Resistance to OsimertinibGeoffrey R. Oxnard, Pasi A. Jänne, Daniel B. Costa et al.|JAMA Oncology|2018Cited by 689
<i>NRG1</i> fusions in solid tumors.Brinda Gupta, Stephen V. Liu, Sharon Wu et al.|Journal of Clinical Oncology|2023Cited by 7
Phosphodiesterase Inhibition to Sensitize Non-Small-Cell Lung Cancer to Pemetrexed: A Double-Edged StrategyAnna V. Ivanina Foureau, Kathryn F. Mileham|Cancers|2024Cited by 2